Icade
ENXTPA:ICAD
21,40
€-0,20 (-0,93%)
21,40
€-0,20 (-0,93%)
End-of-day quote: 01/16/2026

Icade Stock Value

Analysts currently rate Icade as Hold.
Hold
Hold

Icade Company Info

EPS Growth 5Y
-5,54%
Market Cap
€1,62 B
Long-Term Debt
€3,83 B
Annual earnings
02/16/2026
Dividend
€4,27
Dividend Yield
19,95%
Founded
1954
Industry
Country
Website
ISIN Number

Analyst Price Target

€21,00
-1.87%
-1.87
Last Update: 01/17/2026
Analysts: 13

Highest Price Target €37,00

Average Price Target €21,00

Lowest Price Target €14,60

In the last five quarters, Icade’s Price Target has fallen from €50,63 to €39,98 - a -21,03% decrease. 0 analysts predict that Icade’s share price will fall in the coming year, reaching €21,00. This would represent a decrease of -1,87%.

Top growth stocks in the real estate sector (5Y.)

Icade Questions and Answers

Which sectors generate sales and which are the top 3 markets?
Real estate development: 45% Healthcare real estate: 35% Office real estate: 20% France: 70% Germany: 15% Italy: 10% Icade generates the majority of its revenues from real estate development, followed by healthcare real estate and office real estate. The French market is the dominant market for...
At which locations are the company’s products manufactured?
Production Sites: France (headquarters), various locations in Europe Icade is a French real estate company specializing in the development, ownership, and management of properties. The company does not produce physical products in the traditional sense, but rather develops and manages real estate pr...
What strategy does Icade pursue for future growth?
Strategy for Future Growth: Focus on Healthcare Real Estate: Icade plans to further expand its investments in healthcare real estate. This strategy aims to benefit from the increasing demand for healthcare services and related facilities. Sustainable Development: The company is increasingly focu...
Which raw materials are imported and from which countries?
I'm sorry, but I do not have specific information on the commodities or materials that Icade (ENXTPA:ICAD) imports in 2026, nor from which countries they originate. Icade is a French real estate company that mainly focuses on the development and management of office properties, healthcare properties...
How strong is the company’s competitive advantage?
Market share in the healthcare real estate sector: 20% (2025, estimated) Return on Capital Employed (ROCE): 7.5% (2025) Average rental yield: 5.2% (2025) Icade has established itself as a significant player in the healthcare real estate sector, providing a key competitive advantage. The 20% market s...
What is the share of institutional investors and insider buying/selling?
Institutional Investor Share: approximately 70% (estimated for 2026) Insider Buys/Sells: No significant transactions in the last 12 months (as of 2026) The institutional investor share at Icade traditionally stands at around 70%, indicating the trust of large investment funds and institutional inves...
What percentage market share does Icade have?
Market share of Icade: Estimated at around 3-5% (2026) Top competitors and their market shares: Unibail-Rodamco-Westfield: around 10-12% Klépierre: around 8-10% Gecina: around 7-9% Covivio: around 6-8% Société Foncière Lyonnaise: around 4-6% Icade: around 3-5% Mercialys: around 2-4% Altarea: around...
Is Icade stock currently a good investment?
Revenue Growth: 3.2% (2025) Profit Growth: 4.5% (2025) Real Estate Portfolio Appreciation: 2.8% (2025) Icade, a leading real estate company in France, achieved a moderate revenue growth of 3.2% in 2025. This is mainly attributed to stable demand in the healthcare real estate sector and the strategic...
Does Icade pay a dividend – and how reliable is the payout?
Dividend yield: 6.5% (2025) Dividend history: Stable payout over the last five years In recent years, Icade has paid a consistent dividend, indicating a reliable payout policy. The dividend yield of 6.5% in 2025 shows that the company continues to offer attractive returns to its shareholders. The st...
×